DOI QR코드

DOI QR Code

Prevalence of virulence-associated genes and antimicrobial resistance of Campylobacter jejuni from ducks in Gyeongnam Province, Korea

  • Yang, Jung-Wong (Komipharm International Co. Ltd.) ;
  • Kim, Sang-Hyun (Viral Infectious Disease Research Center, Korea Research Institute Bioscience & Biotechnology (KRIBB)) ;
  • Lee, Woo-Won (Veterinary Service Laboratory, Busan Metropolitan city of Health and Environment) ;
  • Kim, Yong-Hwan (College of Veterinary Medicine, Gyeongsang National University)
  • 투고 : 2013.08.29
  • 심사 : 2014.05.07
  • 발행 : 2014.06.30

초록

Total 99 strains of Campylobacter spp. were isolated from 117 cases of duck's fecal samples. Among 99 strains of Campylobacter spp. isolates, 93 strains (93.9%) were C. jejuni and 6 strains (6.1%) were C. coli. Prevalence of virulence and GBS associated genes of 72 C. jejuni isolates was determined by m-PCR. Among the 10 kinds of virulence associated genes, cadF, dnaJ, flaA and ceuE genes were detected in all of C. jejuni isolates from ducks, racR, pldA, iamA, ciaB, virB11 and docC genes were 87.5%, 84.7%, 77.8%, 48.6%, 13.9% and 11.1%, respectively. Antimicrobial susceptibility test was performed on 72 C. jejuni isolates. The rate of resistance were 62.5% for oxytetracycline, 55.6% for kanamycin, 54.2% for enrofloxacin, 50% for ciprofloxacin, 37.5% for tetracycline and nalidixic acid, 18.1% for ampicillin, 15.3% for streptomycin, and 6.9% for ofloxacin. All isolates were susceptible to erythromycin. The adherence (intracellular and extracellular bacteria) abilities of the 20 isolates to INT-407 cells were between $4.21{\pm}1.27{\times}10^4$ CFU/well and $1.053{\pm}0.451{\times}10^6$ CFU/well from the isolates of cj-55 and cj-52, respectively, and that can be expressed as 0.1033% to 5.2655% to the infecting inoculum. The invasion (intracellular bacteria) abilities of the 20 isolates to INT-407 were between $1.00{\pm}1.73{\times}10^3$ CFU/well and $8.47{\pm}5.16{\times}10^4$ CFU/well from the isolates of cj-13 and cj-47, respectively, and that can be expressed as 0.0050% to 0.4235% to the infecting inoculums. The average CFU/well of 20 campylobacters isolated from ducks for adherence to and invasion were $2.646{\pm}2.886{\times}10^5$ and $3.03{\pm}2.7{\times}10^4$ respectively, and that was $1.3230{\pm}1.2139%$ and $0.1516{\pm}0.1343%$ of the starting viable inoculum. There was considerable correlation ($R^2$=0.627) between the adherence and invasion ability of C. jejuni isolates for INT-407 cell.

키워드

참고문헌

  1. Aquino MH, Filgueiras AL, Ferreira MC, Oliveira SS, Bastos MC, Tibana A. 2002. Antimicrobial resistance and plasmid profiles of Campylobacter jejuni and Campylobacter coli from human and animal sources. Lett Appl Microbiol 34: 149-153. https://doi.org/10.1046/j.1472-765x.2002.01060.x
  2. Bacon DJ, Alm RA, Burr DH, Hu L, Kopecko DJ, Ewing CP, Trust TJ, Guerry P. 2000. Involvement of a plasmid in virulence of Campylobacter jejuni. Infect Immun 68: 4384-4390. https://doi.org/10.1128/IAI.68.8.4384-4390.2000
  3. Bakeli G, Sato K, Kumita W, Saito R, Ono E, Chida T, Okamura N. 2008. Antimicrobial susceptibility and mechanism of quinolone resistance in Campylobacter jejuni strains isolated from diarrheal patients in a hospital in Tokyo. J Infect Chemother 14: 342-348. https://doi.org/10.1007/s10156-008-0631-2
  4. Bang DD, Nielsen EM, Scheutz F, Pedersen K, Handberg K, Madsen M. 2003. PCR detection of seven virulence and toxin genes of Campylobacter jejuni and Campylobacter coli isolates from Danish pigs and cattle and cytolethal distending toxin production of the isolates. J Appl Microbiol 94: 1003-1014. https://doi.org/10.1046/j.1365-2672.2003.01926.x
  5. Biswas D, Itoh K, Sasakawa C. 2000. Uptake pathways of clinical and healthy animal isolates of Campylobacter jejuni into INT-407 cells. FEMS Immunol Med Microbiol 29: 203-211. https://doi.org/10.1111/j.1574-695X.2000.tb01524.x
  6. Blaser MJ. 1997. Epidemiologic and clinical features of Campylobacter jejuni infections. J Infect Dis 176: 103-105. https://doi.org/10.1086/514011
  7. Boonmar S, Morita Y, Fujita M, Sangsuk L, Suthivarakom K, Padungtod P, Maruyama S, Kabeya H, Kato M, Kozawa K, Yamamoto S, Kimura H. 2007. Serotypes, antimicrobial susceptibility, and gyr A gene mutation of Campylobacter jejuni isolates from humans and chickens in Thailand. Microbiol Immunol 51: 531-537. https://doi.org/10.1111/j.1348-0421.2007.tb03941.x
  8. Carvalho AC, Ruiz-Palacios GM, Ramos-Cervantes P, Cervantes LE, Jiang X, Pickering LK. 2001. Molecular characterization of invasive and noninvasive Campylobacter jejuni and Campylobacter coli isolates. J Clin Microbiol 39: 1353-1359. https://doi.org/10.1128/JCM.39.4.1353-1359.2001
  9. Chansiripornchai N and Sasipreeyajan J. 2009. PCR detection of four virulence-associated genes of Campylobacter jejuni isolates from Thai broilers and their abilities of adhesion to and invasion of INT-407 cells. J Vet Med Sci. 71(6): 839-44 https://doi.org/10.1292/jvms.71.839
  10. CLSI. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing, 19th informational supplement. M100-S19. Wayne, PA, USA.
  11. Datta S, Niwa H, Itoh K. 2003. Prevalence of 11 pathogenic genes of Campylobacter jejuni by PCR in strains isolated from humans, poultry meat and broiler and bovine faeces. J Med Microbiol 52: 345-348. https://doi.org/10.1099/jmm.0.05056-0
  12. Engberg J, Aarestrup FM, Taylor DE, Gerner-Smidt P, Nachamkin I. 2001. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: Resistance mechanisms and trends in human isolates. Emerg Infect Dis 7: 24-34. https://doi.org/10.3201/eid0701.010104
  13. Friedman CR, Hoekstra RM, Samuel M, Marcus R, Bender J, Shiferaw B, Reddy S, Ahuja SD, Helfrick DL, Hardnett F, Carter M, Anderson B, Tauxe RV. 2004. Risk factors for sporadic Campylobacter infection in the United States: a case-control study in FoodNet sites. Clin Infect Dis 38: 285-296. https://doi.org/10.1086/381598
  14. Gibreel A, Taylor DE. 2006. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 58: 243-255. https://doi.org/10.1093/jac/dkl210
  15. Gilbert CD, Slavik MF. 2005. Evaluation of attachment and penetration abilities of Campylobacter jejuni isolates obtained from humans and chicken carcasses during processing and at retail. J Food Safety 25: 209-223. https://doi.org/10.1111/j.1745-4565.2005.00550.x
  16. Gonzalez I, Grant KA, Richardson PT, Park SF, Collins MD. 1997. Specific identification of the enteropathogens Campylobacter jejuni and Campylobacter coli by using a PCR test based on the ceuE gene encoding a putative virulence determinant. J Clin Microbiol 35: 759-763.
  17. Hendrixson DR, DiRita VJ. 2004. Identification of Campylobacter jejuni genes involved in commensal colonization of the chick gastrointestinal tract. Mol Microbiol 52: 471-484. https://doi.org/10.1111/j.1365-2958.2004.03988.x
  18. Khoshbakht R, Tabatabaei M, Hosseinzadeh S, Shekaforoush SS, Aski HS. 2013. Distribution of nine virulence associated genes in Campylobacter jejuni and C. coli isolated from broiler feces in Shiraz, Southern Iran. Foodborne Pathog Dis 10: 764-770. https://doi.org/10.1089/fpd.2013.1489
  19. Konkel ME, Corwin MD, Joens LA, Cieplak W. 1992. Factors that influence the interaction of Campylobacter jejuni with cultured mammalian cells. J Med Microbiol 37: 30-37. https://doi.org/10.1099/00222615-37-1-30
  20. Konkel ME, Kim BJ, Klena JD, Young CR, Ziprin R. 1998. Characterization of the thermal stress response of Campylobacter jejuni. Infect Immun 66: 3666-3672.
  21. Konkel ME, Kim BJ, Rivera-Amil V, Garvis SG. 1999. Identification of proteins required for the internalization of Campylobacter jejuni into cultured mammalian cells. Adv Exp Med Biol 473: 215-224. https://doi.org/10.1007/978-1-4615-4143-1_22
  22. Krutkiewicz A, Klimuszko D. 2010. Genotyping and PCR detection of potential virulence genes in Campylobacter jejuni and Campylobacter coli isolates from different sources in Poland. Folia Microbiol 55: 167-175 https://doi.org/10.1007/s12223-010-0025-6
  23. Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F, Bengoufa D, Feuillard J, Lavergne A, Gordon JI, Berche P, Guillevin L, Lortholary O. 2004. Immuno-proliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 350: 239-248. https://doi.org/10.1056/NEJMoa031887
  24. Lehtopolku M, Nakari UM, Kotilainen P, Huovinen P, Siitonen A, Hakanen AJ. 2010. Antimicrobial Susceptibilities of Multidrug-Resistant Campylobacter jejuni and C. coli Strains: In Vitro Activities of 20 Antimicrobial Agents. Antimicrob Agents Chemother 54: 1232-1236 https://doi.org/10.1128/AAC.00898-09
  25. Linton D, Gilbert M, Hitchen PG, Dell A, Morris HR, Wakarchuk WW, Gregson NA, Wren BW. 2000. Phase variation of a -1,3- galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni. Mol Microbiol 37: 501-514.
  26. Luechtefeld NA, Blaser MJ, Reller LB, Wang WL. 1980. Isolation of Campylobacter fetus subsp. jejuni from migratory waterfowl. J Clin Microbiol 12: 406-408.
  27. Matsuda M, Moore JE. 2004. Urease-positive thermophilic Campylobacter species. Appl Environ Microbiol 70: 4415-4418. https://doi.org/10.1128/AEM.70.8.4415-4418.2004
  28. Monteville MR, Yoon JE, Konkel ME. 2003. Maximal adherence and invasion of INT 407 cells by Campylobacter jejuni requires the CadF outer-membrane protein and microfilament reorganization. Microbiol 149: 153-165. https://doi.org/10.1099/mic.0.25820-0
  29. Muller J, Schulze F, Muller W, Hanel I. 2006. PCR detection of virulence-associated genes in Campylobacter jejuni strains with differential ability to invade Caco-2 cells and to colonize the chick gut. Vet Microbiol 113: 123-129. https://doi.org/10.1016/j.vetmic.2005.10.029
  30. Nachamkin I, Bohachick K, Patton CM. 1993. Flagellin gene typing of Campylobacter jejuni by restriction fragment length polymorphism analysis. J Clin Microbiol 31: 1531-1536.
  31. Nawaz MS, Wang RF, Khan SA, Khan AA. 2003. Detection of galE gene by polymerase chain reaction in Campylobacters associated with Guillain-Barre syndrome. Mol Cell Probes 17: 313-317. https://doi.org/10.1016/j.mcp.2003.08.002
  32. Nielsen H, Persson S, Olsen KE, Ejlertsen T, Kristensen B, Schonheyder HC. 2010. Bacteraemia with Campylobacter jejuni: no association with the virulence genes iam, cdtB, capA or virB. Eur J Clin Microbiol Infect Dis 29: 357-358. https://doi.org/10.1007/s10096-009-0863-9
  33. Nonga HE, Muhairwa AP. 2010. Prevalence and antibiotic susceptibility of thermophilic Campylobacter isolates from free range domestic duck (Cairina moschata) in Morogoro municipality, Tanzania. Trop Anim Health Prod 42: 165-172. https://doi.org/10.1007/s11250-009-9401-0
  34. Prats G, Mirelis B, Llovet T, Munoz C, Miro E, Navarro F. 2000. Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona. Antimicrob Agents Chemother 44: 1140-1145. https://doi.org/10.1128/AAC.44.5.1140-1145.2000
  35. Prescott JF, Bruin-Mosch CW. 1981. Carriage of Campylobacter jejuni in healthy and diarrhoic animals. Am J Vet Res 42: 164-165.
  36. Ripabelli G, Tamburro M, Minelli F, Leone A, Sammarco ML 2010. Prevalence of virulence-associated genes and cytolethal distending toxin production in Campylobacter spp. isolated in Italy. Comparative Immunol Microbiol Infect Dis 33: 355-364 https://doi.org/10.1016/j.cimid.2008.12.001
  37. Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH, Johnson BP, Moore KA, Osterholm MT. 1999. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. N Engl J Med 340: 1525-1532. https://doi.org/10.1056/NEJM199905203402001
  38. Steinbruckner B, Ruberg F, Vetter-Knoll M. 2001. Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Freiburg from 1992 to 2000. (Abstract B-12) In: Hacker, J. editor. Abstract of scientific presentation of the 11th International workshop on Campylobacter, Helicobacter and related organism, Freiburg, Germany, 291-298.
  39. Talukder KA, Aslam M, Islam Z, Azmi IJ, Dutta DK, Hossain S, Nur-E-Kamal A, Nair GB, Cravioto A, Sack DA, Endtz HP. 2008. Prevalence of virulence genes and cytolethal distending toxin production in Campylobacter jejuni isolates from diarrheal patients in Bangladesh. J Clin Microbiol 46: 1485-1488. https://doi.org/10.1128/JCM.01912-07
  40. Waldenstrom J, Broman T, Carlsson I, Hasselquist D, Achterberg RP, Wagenaar JA, Olsen B. 2002. Prevalence of Campylobacter jejuni, Campylobacter lari, and Campylobacter coli in different ecological guild and taxa of migrating birds. Appl Environ Microbiol 68: 5911-5917. https://doi.org/10.1128/AEM.68.12.5911-5917.2002
  41. Wassenaar TM, Bleumink-Pluym NM, van der Zeijst BA. 1991. Inactivation of Campylobacter jejuni flagellin genes by homologous recombination demonstrates that flaA but not flaB is required for invasion. EMBO J 10: 2055-2061.
  42. Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, Ueda S, Kasama T, Ohnishi A, Hayashi S, Takahashi H, Kamijo M, Hirata K 2001. Animal model of axonal Guillain- Barre' syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 49: 712-720. https://doi.org/10.1002/ana.1012

피인용 문헌

  1. Species at Different Processing Stages in Two Poultry Processing Plants vol.14, pp.3, 2017, https://doi.org/10.1089/fpd.2016.2218